The Genetics Department of the Lifeline Hospital, which was established in 2009, provides the cutting edge technology and most advanced treatment options to parents worldwide. The Hospital has introduced revolutionized genomic treatment, the Next Generation Sequencing technology. Next Generation Sequencing for Pre-implantation genetic diagnosis is cost effective and best with reduced errors.
The tests carried out include Pre-implantation Genetic Diagnosis (PGD) for the genetic profiling of embryos prior to implantation and the pre- implantation genetic screening (PGS), for testing the overall chromosomal normalcy in embryos. Karyotyping, Polymerase Chain Reaction PCR, and Gel Documentation system enables couples to achieve a better result in cases with multiple IVF failure and recurring pregnancy loss. Non-invasive prenatal testing (NIPT ) is done here to detect the DNA defects of the child from mother’s blood.
RGCS (Reproductive Genetics and Cancer Solutions) attached to the Lifeline Hospital is a state-of-the-art molecular diagnostic laboratory established in 2018, and specializing in molecular genetic testing. RGCS is driven to offer the public and healthcare providers the most advanced genetic testing services to ensure precise and personalized medicine.
RGCS was the first genetic testing lab in the private sector in Kerala and it is one of the first premium lab in the country to invest in the latest state-of the art “Next Generation Sequencing” (NGS) technologies. The company offers an extensive menu of highly complex genetic testing in the domains of reproductive genetics, cancer genomics, pharmacogenomics and wellness genetic testing. As we enter the age of genomic medicine, molecular diagnostic will merge with mainstream healthcare and its utility will play a major role in many settings, such as prenatal and preimplantation genetic testing, risk assessment for familial cancer and the diagnosis of many monogenic and multigenic disorders.
RGCS uses the latest and fastest DNA analysis technology to diagnose complex genetic disorders. The complete bench of all new Ion Semi-conductor based next-generation sequencers (NGS) in our lab gives unmatched speed, affordability and accuracy required for all your molecular genetic testing. Atomized robotic workflows with Ion Chef System provides consistent Quality.
Our main services
- Daisy Non Invasive Prenatal Test
Available for Pregnant Moms from 10 weeks of Gestation, with Zero risk of Miscarriage
- Prenatal Screening
Modern methods of biochemical analysis, especially in combination with genetic and biomarker testing, are able to provide a comprehensive answer to reveal early the cause of a disease.
- Preimplantation Genetic Testing
Pre-implantation Genetic Screening and Preimplantation Genetic Diagnosis
- Prenatal Diagnosis
Prenatal diagnosis determine the health of an unborn foetus. There are a variety of noninvasive and invasive techniques available for prenatal diagnosis like Chorionic villus sampling, Percutaneous umbilical blood sampling, Aminocentesis etc.
- Cancer Genetic Testing
Next Generation Sequencing (NGS) Based Multi-gene Panel-Testing for Cancer Diagnosis and Targeted Treatment.
Karyotyping to R/O, Klinefelter syndrome, Turner syndrome, Xxy syndrome, Y chromosome, microdeletion testing.
- Recurrent Pregnancy Loss
Chromosome analysis from product of conception for recurrent pregnancy loss.
The study of variations of DNA and RNA characteristics as related to drug response.
- Genetic Counselling
Genetic counselling is a communication process, which aims to help individuals, couples and families understand and adapt to the medical, psychological, familial and reproductive implications of the genetic contribution to specific health conditions.
BRCAChekTM is a next-generation sequencing test that looks for abnormal variants in BRCA1 and BRCA2 genes. Detection of abnormal variants in either BRCA1 or BRCA2 gene significantly increases a patient’s risk for breast and or ovarian cancer in females and prostate cancer in males.
10% of all prostate cancers are hereditary, meaning that an increased risk for the disease runs in the family. This next-generation sequencing test offered for men with, or at risk of prostate cancer. Test looks for abnormal variants in BRCA1, BRCA2, HOXB13, MLH1, MSH2, MSH6, PMS2 and EPCAM genes.
ColoChekTM is an NGS based Next generation Genetics test method that analyses 11 high-risk colorectal cancer genes (EPCAM, MLH1, MSH2, MSH6, PMS2, MUTYH, APC, BMPR1A, SMAD4, PTEN and STK11) to determine genetic predisposition for the disease. Performed on a blood sample.
Why Choose Us
- Expert Medical Consultation
- Sample Tracking Solution
- CONCIERGE SERVICES! Serves where you are
- Shortest Turnaround Time and Fast Reporting